Published online August 1, 2006
PEDIATRICS Vol. 118 No. 2 August 2006, pp. e488-e500 (doi:10.1542/peds.2006-0738)

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Lee, P. A. Search for Related Content PubMed PubMed Citation Articles by Lee, P. A. Related Collections Endocrinology Social Bookmarking                         What's this?

ENDORSED POLICY STATEMENT

Consensus Statement on Management of Intersex Disorders

Peter A. Lee, MD, PhD^a,b, Christopher P. Houk, MD^c, S. Faisal Ahmed, FRCPCH^d, Ieuan A. Hughes, FMedSci, FRCPCH^b,e in collaboration with the participants in the International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology

^a Department of Pediatrics, Penn State College of Medicine, Hershey, Pennsylvania
^b Co-chairs
^C Department of Pediatrics, Backus Children’s Hospital, Mercer University School of Medicine, Savannah, Georgia
^d Department of Child Health, Royal Hospital for Sick Children, Glasgow, Scotland, United Kingdom
^e Department of Paediatrics, University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom

Key Words: intersex • sexual differentiation • ambiguous genitalia • genital surgery

Abbreviations: DSD—disorder(s) of sex development • CAH—congenital adrenal hyperplasia • CAIS—complete androgen insensitivity syndrome • 5RD2—5--reductase • PAIS—partial androgen insensitivity syndrome • MGD—mixed gonadal dysgenesis

The first 300 words of the full text of this article appear below.

The birth of an intersex child prompts a long-term management strategy that involves myriad professionals working with the family. There has been progress in diagnosis, surgical techniques, understanding psychosocial issues, and recognizing and accepting the place of patient advocacy. The Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology considered it timely to review the management of intersex disorders from a broad perspective, review data on longer-term outcome, and formulate proposals for future studies. The methodology comprised establishing a number of working groups, the membership of which was drawn from 50 international experts in the field. The groups prepared previous written responses to a defined set of questions resulting from evidence-based review of the literature. At a subsequent gathering of participants, a framework for a consensus document was agreed. This article constitutes its final form.

NOMENCLATURE AND DEFINITIONS

Advances in identification of molecular genetic causes of abnormal sex with heightened awareness of ethical issues and patient advocacy concerns necessitate a reexamination of nomenclature.¹ Terms such as "intersex," "pseudohermaphroditism," "hermaphroditism," "sex reversal," and gender-based diagnostic labels are particularly controversial. These terms are perceived as potentially pejorative by patients² and can be confusing to practitioners and parents alike. We propose the term "disorders of sex development" (DSD), as defined by congenital conditions in which development of chromosomal, gonadal, or anatomic sex is atypical.

The proposed changes in terminology are summarized in Table 1. A modern lexicon is needed to integrate progress in molecular genetic aspects of sex development. Because outcome data in individuals with DSD are limited, it is essential to use precision when applying definitions and diagnostic labels.^3,4 It is also appropriate to use terminology that is sensitive to the concerns of patients. The ideal nomenclature should be sufficiently flexible to incorporate new information yet robust enough to maintain a . . . [Full Text of this Article]

Address correspondence to Peter A. Lee, MD, PhD, Department of Pediatrics, MC-085, Penn State College of Medicine, Milton S. Hershey Medical Center, Box 850, 500 University Dr, Hershey, PA 17033-0850. E-mail: plee@psu.edu

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

The following policy statement has been revised:

Evaluation of the Newborn With Developmental Anomalies of the External Genitalia

, , and
Pediatrics 106: 138-142. [Full Text]

This article has been cited by other articles:

				R. Ritchie, J. Reynard, and T. Lewis Intersex and the Olympic Games J R Soc Med, August 1, 2008; 101(8): 395 - 399. [Full Text] [PDF]

				K. H. Mayer, J. B. Bradford, H. J. Makadon, R. Stall, H. Goldhammer, and S. Landers Sexual and Gender Minority Health: What We Know and What Needs to Be Done Am J Public Health, June 1, 2008; 98(6): 989 - 995. [Abstract] [Full Text] [PDF]

				C. Chi, H. C. Lee, and E. K. Neely Ambiguous Genitalia in the Newborn NeoReviews, February 1, 2008; 9(2): e78 - e84. [Abstract] [Full Text] [PDF]

				L. O'Keefe Sensitive approach: Team modernizes guidelines for managing intersex disorders AAP News, December 1, 2006; 27(12): 37 - 38. [Full Text]